InsiderClue
Insiders · Profile

Farwell Wildon

Chief Medical Officer at Dyne Therapeutics. Filing since 2 Mar 2022. CIK 0001847941

Company
Date
Role
Action
Shares
Amount
Of holding
DYN Dyne Therapeutics, Inc.
19 Aug 2024
Chief Medical Officer
Sold on a plan
2,321
$104.73K
1.6%
DYN Dyne Therapeutics, Inc.
11 Jun 2024
Chief Medical Officer
Sold on a plan
2,636
$82.43K
1.8%
DYN Dyne Therapeutics, Inc.
16 May 2024
Chief Medical Officer
Sold on a plan
2,381
$67.31K
1.6%
DYN Dyne Therapeutics, Inc.
12 Mar 2024
Chief Medical Officer
Sold on a plan
1,030
$26.35K
0.7%
DYN Dyne Therapeutics, Inc.
11 Mar 2024
Chief Medical Officer
Sold on a plan
1,585
$40.73K
1.0%
DYN Dyne Therapeutics, Inc.
7 Mar 2024
Chief Medical Officer
Sold on a plan
9,921
$256.58K
6.1%
DYN Dyne Therapeutics, Inc.
28 Feb 2024
Chief Medical Officer
Sold on a plan
407
$10.18K
0.2%
DYN Dyne Therapeutics, Inc.
12 Feb 2024
Chief Medical Officer
Sold on a plan
5,493
$137.71K
3.3%
DYN Dyne Therapeutics, Inc.
26 Jan 2024
Chief Medical Officer
Sold on a plan
100
$2.50K
0.1%
DYN Dyne Therapeutics, Inc.
12 Dec 2023
Chief Medical Officer
Sold on a plan
978
$10.32K
0.6%
DYN Dyne Therapeutics, Inc.
11 Dec 2023
Chief Medical Officer
Sold on a plan
1,688
$18.10K
1.0%
DYN Dyne Therapeutics, Inc.
12 Sep 2023
Chief Medical Officer
Sold at will
1,707
$17.77K
1.9%
DYN Dyne Therapeutics, Inc.
13 Jun 2023
Chief Medical Officer
Sold at will
1,698
$21.11K
1.8%
DYN Dyne Therapeutics, Inc.
14 Mar 2023
Chief Medical Officer
Sold, plan not stated
7,441
$99.19K
7.4%
DYN Dyne Therapeutics, Inc.
12 Dec 2022
Chief Medical Officer
Sold, plan not stated
628
$6.83K
0.6%
DYN Dyne Therapeutics, Inc.
11 Mar 2022
Chief Medical Officer
Sold, plan not stated
640
$5.59K
1.0%
DYN Dyne Therapeutics, Inc.
2 Mar 2022
Chief Medical Officer
Sold, plan not stated
5,617
$48.08K
7.8%
17 decisions on file.